337 related articles for article (PubMed ID: 30111667)
21. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells.
Zhang H; Li M; Zhou X; Tang L; Chen G; Zhang Y
Eur J Med Chem; 2024 Jun; 272():116497. PubMed ID: 38759453
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2,3,4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors.
Salehi M; Amini M; Ostad SN; Riazi GH; Assadieskandar A; Shafiei B; Shafiee A
Bioorg Med Chem; 2013 Dec; 21(24):7648-54. PubMed ID: 24238904
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety.
Ragab FAF; Abou-Seri SM; Abdel-Aziz SA; Alfayomy AM; Aboelmagd M
Eur J Med Chem; 2017 Sep; 138():140-151. PubMed ID: 28667871
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents.
Eldehna WM; Hassan GS; Al-Rashood ST; Al-Warhi T; Altyar AE; Alkahtani HM; Almehizia AA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):322-332. PubMed ID: 30722708
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents.
Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B
Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861
[TBL] [Abstract][Full Text] [Related]
28. Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.
Siddiqui-Jain A; Hoj JP; Hargiss JB; Hoj TH; Payne CJ; Ritchie CA; Herron SR; Quinn C; Schuler JT; Hansen MDH
Bioorg Med Chem Lett; 2017 Sep; 27(17):3992-4000. PubMed ID: 28780159
[TBL] [Abstract][Full Text] [Related]
29. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of dihydrofolate reductase as antitumor agents: design, synthesis and biological evaluation of a series of novel nonclassical 6-substituted pyrido[3,2-d]pyrimidines with a three- to five-carbon bridge.
Li H; Fang F; Liu Y; Xue L; Wang M; Guo Y; Wang X; Tian C; Liu J; Zhang Z
Bioorg Med Chem; 2018 May; 26(9):2674-2685. PubMed ID: 29691154
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, anticancer evaluation, molecular docking and cell cycle analysis of 3-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidine derivatives as potent histone lysine demethylases (KDM) inhibitors and apoptosis inducers.
Metwally NH; Mohamed MS; Ragb EA
Bioorg Chem; 2019 Jul; 88():102929. PubMed ID: 31015179
[TBL] [Abstract][Full Text] [Related]
33. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Antipoliferative Activities of Novel Substituted Imidazole-Thione Linked Benzotriazole Derivatives.
Khayyat AN; Mohamed KO; Malebari AM; El-Malah A
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641526
[TBL] [Abstract][Full Text] [Related]
36. Novel Benzo[B]Furans with Anti-Microtubule Activity Upregulate Expression of Apoptotic Genes and Arrest Leukemia Cells in G2/M Phase.
Królewska-Golińska K; Cieślak MJ; Sobczak M; Dolot R; Radzikowska-Cieciura E; Napiórkowska M; Wybrańska I; Nawrot B
Anticancer Agents Med Chem; 2019; 19(3):375-388. PubMed ID: 30465514
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and antitumor activity evaluation of trifluoromethyl-substituted pyrimidine derivatives.
Liu L; Wang Z; Gao C; Dai H; Si X; Zhang Y; Meng Y; Zheng J; Ke Y; Liu H; Zhang Q
Bioorg Med Chem Lett; 2021 Nov; 51():128268. PubMed ID: 34302974
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
